CD44 has also been considered as a cancer stem cell (CSC) marker in several malignancies of hematopoietic and epithelial origin [20], and is closely related with tumor progression and drug resistance [21,22,23] in several tumors including ovarian cancer [15,16]. Here, CD44 is linked to ovarian carcinoma.